Calroy Health Sciences

Recent Posts

The Top 3 Questions about Lp(a), by Dr. Kahn

Posted by Calroy Health Sciences on May 26, 2021 10:20:00 AM

 

By Joel Kahn, MD, FACC

Read More

Topics: Joel Kahn, MD, FACC

New Modalities Needed to Stop the Progression of Vascular Impairment

Posted by Calroy Health Sciences on May 12, 2021 11:23:28 AM

Stokes: A new strategy for vascular support

In this short video, family practitioner Dr. George Stokes explains the better outcomes he’s achieved by going beyond traditional approaches to vascular health.

Read More

Topics: George Stokes, MD

Practice Implementation Resource Guide Overview

Posted by Calroy Health Sciences on Apr 21, 2021 8:40:54 AM

 

What's Inside?

Read More

It’s Not Just the Heart: Why Every Patient Should Know About the Endothelial Glycocalyx

Posted by Calroy Health Sciences on Apr 12, 2021 10:08:28 AM
Read More

Topics: Jack Wolfson, DO, FACC

How a Leading Cardiologist Measures Vascular Health

Posted by Calroy Health Sciences on Mar 25, 2021 5:59:52 AM

Tests, labs, and symptoms that Jack Wolfson, DO, uses to track patients’ progress

Read More

Topics: Jack Wolfson, DO, FACC

Measuring Vascular Health: Effective Tools for Every Practitioner

Posted by Calroy Health Sciences on Jan 15, 2021 2:07:27 PM

 

Measuring vascular health: You asked, experts answer

Read More

Topics: Joel Kahn, MD, FACC, Kristine Burke, MD

Stubborn Arterial Plaque: Case Series with Kristine Burke, MD

Posted by Calroy Health Sciences on Jan 4, 2021 3:19:59 PM

 

Plaque Regression in Clinical Practice

Read More

Topics: Kristine Burke, MD

Joel Kahn, MD, on the New Focus for Vascular Protection

Posted by Calroy Health Sciences on Dec 10, 2020 12:31:57 PM

"The endothelial glycocalyx is a very hot topic."

Read More

Topics: Joel Kahn, MD, FACC

The Endothelium as an Endocrine Organ

Posted by Calroy Health Sciences on Nov 30, 2020 2:40:25 PM

Hormones at the tissue level

Read More

Atherosclerosis: A New Perspective

Posted by Calroy Health Sciences on Nov 30, 2020 10:29:19 AM

At 600,000 fatalities a year, CVD accounts for 25% of American deaths. Stroke kills another 130,000.1 The precursor to most of these deaths is atherosclerosis: the development of plaque in the arterial wall.

While some plaque is relatively stable, it is the unstable plaque that causes most events.2 This more vulnerable plaque is liable to erupt and deposit its contents into the bloodstream, causing dangerous clots. 

Read More

Arterosil Research Summary 

Free Download 

Numerous cellular, animal and human studies have been conducted to evaluate the biological activities, mode of mechanisms, and therapeutic benefits of Arterosil, a patent-pending nutraceutical. Studies include:

  • MRI Carotid Plaque Regression Study
  • Glycocalyx Regeneration Study
  • Leukocyte Adhesion Study
  • Arterial Elasticity Study
  • Hypertension Study

Download Arterosil's Research Summary here.

Subscribe Here!

Recent Posts